Mette Østergaard

<i>WT1</i> gene expression: an excellent tool for monitoring minimal residual disease in 70% of acute myeloid leukaemia patients – results from a single‐centre study

Mette Østergaard, Lene Olesen, Henrik Hasle et al. · British Journal of Haematology · 2004 · 195 citations

Strikingly different molecular relapse kinetics in NPM1c, PML-RARA, RUNX1-RUNX1T1, and CBFB-MYH11 acute myeloid leukemias

Hans Beier Ommen, Susanne Schnittger, Jelena Jovanović et al. · Blood · 2009 · 139 citations · Full text

Polymorphisms in the xenobiotic transporter Multidrug Resistance 1 (MDR1) and interaction with meat intake in relation to risk of colorectal cancer in a Danish prospective case-cohort study

Vibeke Andersen, Mette Østergaard, Jane Christensen et al. · BMC Cancer · 2009 · 98 citations · Full text

Gene expression profiling of Polycomb, Hox and Meis genes in patients with acute myeloid leukaemia

Lykke Grubach, Caroline Juhl‐Christensen, Anita Rethmeier et al. · European Journal Of Haematology · 2008 · 90 citations

Mixed-phenotype Acute Leukemia, Genetics, Gene Expression Profiling +20

Relapse prediction in acute myeloid leukaemia patients in complete remission using <i>WT1</i> as a molecular marker: development of a mathematical model to predict time from molecular to clinical relapse and define optimal sampling intervals

Hans Beier Ommen, Charlotte Guldborg Nyvold, Karin Brændstrup et al. · British Journal of Haematology · 2008 · 73 citations · Full text